NASDAQ
No price data available for this timeframe.
Galectin Therapeutics Inc. (GALT) has a eps (basic) of $-0.48 as of Wednesday, December 31, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.